JiMED Inc.
Pioneering Hope: Advanced Brain-Machine Interface Technology
Worldwide, more than 4 million people are diagnosed each year with "Locked-in syndrome" - a condition in which patients are fully conscious but unable to move or communicate due to severe neurological disorders or trauma. The company has developed a wireless implantable Brain-computer interface, the world's first medical device that translates brain signals into commands for external digital devices. The company will first enable communication for patients with locked-in syndrome and then enable more patients to operate external digital devices such as computers and assistive devices. This breakthrough technology enables patients to perform activities independently, giving them renewed dignity and autonomy in their daily lives.
- Establishment Date
- March 2020
- Business
- Development, manufacturing, and sales of wireless implantable Brain-Machine Interface (BMI)/Brain-Computer Interface (BCI) systems
- CEO
- President & CEO Jin Nakamura
KII’s Perspective
The company’s pioneering BCI technology is poised to transform the medical device market. Combining significant social impact through improving the lives of patients with untreatable neurological conditions and strong market protection through its proprietary technology, the company is strategically positioned for global expansion.
KII growth support
Financing assistance, Appointed as director, Business strategy support, Business alliance support, Public relations support